Please log in to determine if you are eligible to purchase PT Programs.
NGS HEMATOLOGIC MALIGNANCIES - NGSHM
NGSHM
Analytes/procedures in bold type are regulated for proficiency testing by the Centers for Medicare & Medicaid Services (CMS).

Procedure Challenges per Shipment Number of Shipments
Next‑generation sequencing 3 Two shipments per year

Additional Information

  • This is a methods‑based proficiency challenge for laboratories performing targeted next‑generation sequencing of genes or mutation hotspots in hematologic malignancies.
  • This program includes variants present with a variant allele fraction (VAF) potentially as low as 5%.

Program Information

  • Three 1.0‑μg gDNA (50 ng/μL) specimens

Shipping Schedule

  • Shipment A: April 29
  • Shipment B: October 28






Customers Who Bought This Item Also Bought
NGS SOLID TUMOR
VIEW DETAILS >
NGS BIOINFORMATICS HYBRID - HEME MALIGNANCIES
VIEW DETAILS >